INTRODUCTION
============

Although the pathogenesis has not been defined, a number of mediators have been thought to be candidates responsible for glomerulonephritis(GN)^[@b1-kjim-9-2-93-7])^. Mononuclear cells(MNC) have been reported to be identified in the glomeruli of patients with GN^[@b2-kjim-9-2-93-7],[@b3-kjim-9-2-93-7])^. It's suggested that MNC influx are associated with increased extracellular matrix(ECM) expression^[@b4-kjim-9-2-93-7])^. It has been reported that glomerular cells, especially mesangial cells, as well as MNC synthesize ECM proteins like collagen and fibronectin^[@b5-kjim-9-2-93-7])^, and release and re-spond to cytokine growth factors^[@b6-kjim-9-2-93-7]--[@b8-kjim-9-2-93-7])^. Transforming growth factor(TGF)*β* has marked effects on ECM accumulation by cultured mesangial cells^[@b9-kjim-9-2-93-7]--[@b12-kjim-9-2-93-7])^, while it inhibits proliferation of glomerular cells. The treatment with anti-TGF *β* antibody was reported to prevent proteoglycan production in experimental GN^[@b12-kjim-9-2-93-7])^. Tumor necrosis factor(TNF)α has the several effects on mesangial cells such as mesangiolysis, cell proliferation or procoagulant activity^[@b13-kjim-9-2-93-7],[@b14-kjim-9-2-93-7])^. Serum TNFα and TNFα mRNA in kidney were found to be increased in GN^[@b15-kjim-9-2-93-7]--[@b18-kjim-9-2-93-7])^. Also, reactive oxygen species(ROS) released from leukocytes or glomerular cells, such as hydroxyl radical, were reported to be associated with proteolysis and prostaglandin synthesis, and to be related to some GN^[@b19-kjim-9-2-93-7])^.

The expansion of mesangial ECM and cell proliferation appears to be important pathologic features in GN, and may contribute to the development of sclerosis^[@b20-kjim-9-2-93-7])^. It was reported that the antibodies to ECM proteins stain in the glomerular mesangium, and mRNAs for ECM protein are increased in several GN^[@b21-kjim-9-2-93-7]--[@b23-kjim-9-2-93-7])^. Recently, the adhesion molecules such as *β*1 integrin and intercellular adhesion molecules(ICAM)-1 have been detected in glomerulus^[@b24-kjim-9-2-93-7],[@b25-kjim-9-2-93-7])^. They are suggested to play an important role as mediators of cell-matrix or cell-cell interactions in immune or inflammatory processes. The *β*1 integrin expression are known to be regulated by TGF *β*, and the ICAM-1 expression by TNFα or interleukin-1. Their expression was reported to be altered in some GN^[@b26-kjim-9-2-93-7]--[@b30-kjim-9-2-93-7])^.

However, the direct relationships between MNC and the expression of adhesion molecules on mesangial cells have not been delineated yet.

Therefore, this study was performed to observe the direct effects of conditioned media (CM) of cultured MNC on the expression of *β*1 integrin and ICAM-1 on mesangial cells, together with thymidine incorporation, and the modulation by TGF-*β*, TNFα, or hydroxyl radical on these was investigated. Also these were examined in anti-Thy mesangial proliferative GN(MsPGN) or puromycin aminonucleoside nephrosis(PAN).

MATERIALS AND METHODS
=====================

Induction of Experimental Models
--------------------------------

Anti-Thy MsPGN was induced in Sprague-Dawley rats(5--6 wk old) by intravenous administration of 1 ml of anti-thymocyte antibody per 100g of body weight followed by 1 ml of normal rabbit serum^[@b12-kjim-9-2-93-7])^. Also PAN was induced by intravenous administration of 1.5mg of the aminonucleoside of puromycin per 100g of body weight^[@b31-kjim-9-2-93-7])^. The rats were killed on day 3 for histologic examination of kidney tissue and isolation of MNC for culture.

Rat Mononuclear Cell Culture
----------------------------

Spleen cells were obtained from rats with Control, MsPGN or PAN and, after removal of erythrocytes, were cultured at 0.5×10^7^ cells/ml of RPMI 1640 media supplemented with 10% heat-inactivated fetal calf serum in a humidified atmosphere of 5% CO~2~ in air at 37^°^C. After 48h, the CM were harvested, filtered, and applied to the cultured mesangial cells.

Rat Mesangial Cell Culture
--------------------------

Glomeruli were isolated using the graded sieving technique, and washed three times in PBS. For pure mesangial cell culture, collagenase treated glomeruli were plated on culture dishes in DMEM media containing 17% heat-inactivated fetal bovine serum, glutamine, penicillin, streptomycin, amphotericin B, and insulin. It was examined if these cells have prominent intracellular myosin fibrils, are negative with antibodies to rat la antigen and factor VII by immunofluorolescent staining as described, and are capable of growth in D-valine substituted medium and not sensitive to puromycin^[@b11-kjim-9-2-93-7],[@b31-kjim-9-2-93-7])^. Near confluent cells in the third to fourth passage were used in these studies.

Assessment of Expression of *β*1 Integrin and ICAM-1 on Mesangial Cells
-----------------------------------------------------------------------

1×10^4^/well mesangial cells were plated into 96 well plates and cultured for 48h. After adding each components such as CM of MNC, antibodies against TGF *β* or TNFα(Genzyme, Cambridge, MA, USA) and a hydroxyl radical scavenger, dimethylthiourea, cells were cultured for 48 h and washed with DMEM twice. Each plates were fixed with 1% paraformaldehyde for 15 min at room temperature and washed. After blocking unbound region with 200μl of 2% bovine serum albumin, 100 μl of mouse ant-rat ICAM-1 antibody(Serotec, Oxford, England) and anti-rat *β*1 integrin antibody(Chemicon, Temecula, CA, USA) were added. Then alkaline phosphatase conjugated goat anti-mouse antibody(Gibco BRL) was added and cells were incubated for 1 h. After adding p-nitrophenyl phosphate, reaction was stopped with 3 N NaOH and the optical density(OD) was read at 405nm.

Thymidine Incorporation Assays
------------------------------

Cells were plated at 1×10^4^ cells per well in 96-well plates in DMEM medium. One μCi per well of \[^3^H\] thymidine(New England Nuclear, Boston, Massachusetts, USA) was added after the medium was replaced according to the experimental design as described above. After an 16h incubation, the contents of each well were counted in a liquid scintillation counter.

Statistics
----------

Results are expressed as the mean ± standard deviation of the mean(SD). Comparison among groups were made by ANOVA using the Newman-Keuls multiple comparison test. Comparison between groups were made using Student's paired t-test for normal distributed data. Significance was assigned at the p\<0.05 levels.

RESULTS
=======

Experimental Glomerulonephritis
-------------------------------

On day 3 after the administration of anti-rat thymocyte serum, light microscopy showed mild hypercellularity in some tufts of glomeruli of Ms PGN rats. Also small electon-dense deposits were seen in the glomerular mesangia by electron microscopy. In PAN models the focal and segmental obliteration of foot processes was observed, and the swelling of the visceral epithelial cells with villous transformations became evident.

*β*1 Integrin Expression on Meangial Cells
------------------------------------------

The expression of *β*1 integrin was measured by ELISA on mesangial cells cultured for 48 h, after addition of CM of MNC harvested from rats with GN on day 3. The expression of *β*1 integrin on mesangial cells was decreased by 20%, compared to media alone, by the addition of CM of MNC from Control([Fig. 1](#f1-kjim-9-2-93-7){ref-type="fig"}). It was higher in MsPGN than in Control(n=6, 122 ± 12% vs. 102 ± 15%, p \< 0.05)([Fig. 2](#f2-kjim-9-2-93-7){ref-type="fig"}). Further studies utilizing neutralizing antibody were perfomed to determine whether the above changes are modulated by TGF *β*. The increased expression was prevented by 25μg/ml anti-TGF *β* antibody(96 ± 11%)([Fig. 2](#f2-kjim-9-2-93-7){ref-type="fig"}). But, the treatment with anti-TGF *β* antibody also decreased the expression of *β*1 integrin in Control(71 ± 10%). Marginal increments in the expression of *β*1 integrin was noticed in PAN(113 ± 10%)(p\<0.05).

ICAM-1 Expression on Mesangial Cells
------------------------------------

The expression of ICAM-1 was increased by 44% by the addition of CM of MNC([Fig. 1](#f1-kjim-9-2-93-7){ref-type="fig"}). While there were no differences among groups ([Table 1](#t1-kjim-9-2-93-7){ref-type="table"}), the ratio of the expression of ICAM-1 to thymidine incorporation was higher in MsPGN and PAN than in Control. Further studies utilizing neutralizing antibody showed that the increased expression was completely prevented by 50μl/ml anti-TNFα antibody([Table 1](#t1-kjim-9-2-93-7){ref-type="table"}), and TNFα stimulated the expression of ICAM-1 by 33%.

Thymidine Incorporation Assay on Mesangial Cells
------------------------------------------------

\[^3^H\] thymidine incorporation was examined to observe the cell growth in relation to *β*1 integrin expression or cytokine growth factors. It was greatly suppressed by adding CM of MNC from Control([Fig. 1](#f1-kjim-9-2-93-7){ref-type="fig"}). Also it was lower in MsPGN(43±5×10^2^cpm), and PAN(37±7×10^2^cpm) than in Control(122 ± 20 × 10^2^cpm), which was mitigated by anti-TGF*β* and anti-TNFα([Table 2](#t2-kjim-9-2-93-7){ref-type="table"}). Especially the thymidine incorporation in MsPGN was reversed to normal by anti-TNFα(101±9×10^2^cpm).

Hydroxyl Radical Scavenger Treatment
------------------------------------

To investigate the relationship between hydroxyl radical and the above changes, a hydroxyl radical scavenger, 10mmol/l dimethylthiourea, was added. Then, the increased expression of *β*1 integrin induced with CM of MNC from MsPGN was prevented(98 ± 8%). There were no changes in ICAM-1 expression after dimethylthiourea treatment. The decrease in thymidine incorporation induced with the CM of MNC from MsPGN was mitigated with dimethylthiourea(43 ± 5 × 10^2^cpm vs. 64±4×10^2^cpm)(p\<0.05).

DISCUSSION
==========

These experiments were perfomed to test the hypothesis that 1) the CM of MNC affects the expression of *β*1 integrin or ICAM-1 on mesangial cells, which may mediate the ECM accumulation and cell proliferation in glomeruli leading to glomerulosclerosis in glomerulonephritis; and 2) some cytokine growth factors, or hydroxyl radical released by MNC have the central role in a series of these changes.

According to our data, the CM of MNC from Control suppressed the *β*1 integrin expression and thymidine incorporation. Especially it increased ICAM-1 expression on mesangial cells by 44%. This study showed that MNC may have the important factors regulating mesangial cell phenotype. The above changes were in part ascribed to the effects of TGF*β* or TNFα. The increase in ICAM-1 expression was prevented by anti-TNFα.

In anti-Thy MsPGN, mesangiolysis occurs by the formation of in situ immune complex during the first 1 or 2 days, and later is followed by cell proliferation^[@b32-kjim-9-2-93-7],[@b33-kjim-9-2-93-7])^. PAN is the model of nephrotic syndrome caused by epithelial cell injury^[@b18-kjim-9-2-93-7],[@b34-kjim-9-2-93-7])^. In this study, the expression of *β*1 integrin on mesangial cells was increased by the CM of MNC from MsPGN group on day 3. The *β*1 subunit associates with multiple α's, comprising at least nine integrin. The *β*1 integrin binds to the ligands such as collagen, laminin, fibronectin or Arg-Gly-Asp sequence, and can promote cell adhesion to ECM known to accumulate in GN. There is evidence that the *β*1 integrin affects matrix metabolism^[@b24-kjim-9-2-93-7])^. The binding of mesangial cells to collagen IV, via the *β*1 integrin, stimulates the original construction of new matrix starting at the cell-matrix contact site. Also it's suggested that MNC may have the central role in the regulation of *β*1 integrin expression in anti-Thy MsPGN, consistent with the fact that this GN is monocyte dependent^[@b32-kjim-9-2-93-7])^. TGF *β* is known to stimulate the production of *β*1 integrin, together with ECM protein, contributing to matrix expansion or glomerulosclerosis^[@b10-kjim-9-2-93-7],[@b24-kjim-9-2-93-7])^. The treatment with anti-TGF *β* antibody prevented the overexpression of *β*1 integrin induced with the CM of MNC from MsPGN in this study. These in vitro data are further consistent with the recent report that *β*1 integrin expression is coordinated with TGF *β*-induced ECM protein synthesis in glomeruli of rats with anti-Thy MsPGN^[@b30-kjim-9-2-93-7])^. Moreover, our experimental methods may be beneficial to test the direct relationships between *β*1 integrin and MNC in GN. However, the increase in *β*1 integrin expression was small and anti-TGF *β* antibody also suppressed the *β*1 integrin expression induced by the CM of MNC from control. This cannot rule out that the other factors can also be candidates for these changes. Our preliminary data showed interleukin-1 *β* increased the expression of *β*1 integrin by 24%, which is also supported by other work^[@b35-kjim-9-2-93-7])^, but in conflict with a recent report^[@b30-kjim-9-2-93-7])^.

The expression of ICAM-1 on mesangial cells was increased by 44% by the addition of CM of MNC from Control, and was completely prevented by anti-TNFα antibody. Also our experiments showed that TNFα stimulated the expression of ICAM-1, consistent with other studies^[@b25-kjim-9-2-93-7],[@b36-kjim-9-2-93-7])^. Altogether this supports the role of TNFα produced by MNC on ICAM-1 expression. However, in these experiments ICAM-1 expression was not different among groups. This might be explained by the decreased cell viability due to mesangiolysis in MsPGN or the presence of certain factors other than TNFα. The ratio of the expression of ICAM-1 to thymidine incorporation was higher in GN groups than in control.

While the thymidine incorporation was suppressed by the addition of CM of MNC from Control, it was lower in MsPGN and PAN than in Control. The decrease in thymidine incorporation was mitigated by anti-TGF *β* or anti-TNFα. The findings suggest that the decreased cellularity by CM of MNC may be, in part, due to anti-proliferative action of TGF *β* or cytolytic effects of TNFα^[@b11-kjim-9-2-93-7],[@b13-kjim-9-2-93-7])^. Especially the thymidine incorporation in MsPGN was reversed to normal by anti-TNFα. Also one may speculate that there may be the close relationships between adhesion molecules, some cytokine growth factors, and cellularity on mesangial cells in GN^[@b37-kjim-9-2-93-7])^. In our experiments the decreased cellularity was seen concurrent with the increase in *β*1 integrin in MsPGN.

A hydroxyl radical scavenger treatment prevented the overexpression of *β*1 integrin induced by CM of MNC from MsPGN group, like anti-TGF *β*. Because cytokines like interleukin-1 and TNFα stimulate ROS generation in mesangial cells^[@b38-kjim-9-2-93-7])^, the relationships between hydroxyl radical and the expression of *β*1 integrin, through cytokines, can be speculated.

In conclusion, the expression of *β*1 integrin and ICAM-1, and the thymidine incorporation on mesangial cells are directly regulated by MNC, maybe through factors such as TGF *β* or TNFα. In MsPGN, the overexpression of *β*1 integrin induced by MNC through TGF *β* or hydroxyl radical on day 3 may be related to the pathogenesis. Further studies are necessary to investigate the expression of *β*1 integrin and ICAM-1 in GN at the late time points, and also the modulation by other cytokine growth factors or systems such as protein kinase C or eicosanoid.
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![Effects of the conditioned media of mononuclear cells on the expression of *β*1 integrin and ICAM-1, and\[^3^H\] thymidine incorporation. The conditioned media of mononuclear cells from Control(■) suppressed the *β*1 integrin expression and thymidine incorporation, and increased ICAM-1 expression on mesangial cells, compared to media alone(□). a : p\<0.05 vs. media alone.](kjim-9-2-93-7f1){#f1-kjim-9-2-93-7}

![The expression of *β*1 integrin on mesangial cells after the addition of conditioned media of mononuclear cells harvested from rats with glomerulonephritis. The expression in MsPGN was higher than in Control. The overexpression was prevented by the tratment with 25μg/ml anti-TGF *β* antibody(■), which also decreased the *β*1 integrin expression in Control. a : p \< 0.05 vs. Control, b : p \< 0.05 vs. without anti-TGF *β* antibody(□).](kjim-9-2-93-7f2){#f2-kjim-9-2-93-7}

###### 

Effect of the Conditioned Media of Mononuclear Cells on the Expression of ICAM-1 on Mesangial Cells

  Mononuclear cellconditioned media   ICAM-1(% of mean control value)   
  ----------------------------------- --------------------------------- --------------------------------------------------------
  Control                             100 ± 12                          72 ± 11[^a^](#tfn2-kjim-9-2-93-7){ref-type="table-fn"}
  MsPGN                               102 ± 7                           69 ± 14[^a^](#tfn2-kjim-9-2-93-7){ref-type="table-fn"}
  PAN                                 94 ± 8                            75 ± 11[^a^](#tfn2-kjim-9-2-93-7){ref-type="table-fn"}

Data are expressed as means±S.D.(=6).

P\<0.05 vs. without anti-TNFα

###### 

Effect of the Conditioned Media of Mononuclear Cells on\[^3^H\] Thymidine Incorporation on Mesangial Cells

  Mononuclear cell conditioned media   \[^3^H\] thymidine incorporation(10^2^cpm)                                                                       
  ------------------------------------ ------------------------------------------------------- -------------------------------------------------------- -------------------------------------------------------
  Control                              122 ± 20                                                170 ± 6[^b^](#tfn5-kjim-9-2-93-7){ref-type="table-fn"}   141 ± 15
  MsPGN                                43 ± 5[^a^](#tfn4-kjim-9-2-93-7){ref-type="table-fn"}   101 ±9[^b^](#tfn5-kjim-9-2-93-7){ref-type="table-fn"}    64 ± 8[^b^](#tfn5-kjim-9-2-93-7){ref-type="table-fn"}
  PAN                                  37 ± 7[^a^](#tfn4-kjim-9-2-93-7){ref-type="table-fn"}   56 + 6[^b^](#tfn5-kjim-9-2-93-7){ref-type="table-fn"}    49 ± 5[^b^](#tfn5-kjim-9-2-93-7){ref-type="table-fn"}

Values are mean±S.D.(n=6).

P\<0.05 vs. control

P\<0.05 vs. without

[^1]: The short title; β1 integrin and ICAM-1 on mesangial cells
